Successful treatment of severe recalcitrant erosive oral lichen planus with topical tacrolimus
- PMID: 16405611
- DOI: 10.1111/j.1468-3083.2005.01338.x
Successful treatment of severe recalcitrant erosive oral lichen planus with topical tacrolimus
Abstract
Oral lichen planus (LP) is a severe, painful form of LP, and is often resistant to topical corticosteroid therapy. Recently, open trials demonstrated that topical tacrolimus therapy was effective for the treatment of chronic erosive oral LP. We report two cases with severe recalcitrant erosive oral LP, who dramatically benefited from topical tacrolimus therapy. In case 1, a 64-year-old man presented with a 5-month history of painful erosions on his entire lower lip and buccal mucosa. Physical and histological examination confirmed a diagnosis of LP. He experienced rapid relief from pain and a dramatic improvement was obtained within 5 weeks of topical tacrolimus treatment. No significant irritation was observed and blood tacrolimus level was kept within a safe level (2.5 ng/mL). In case 2, a 68-year-old man developed painful erosions on his right lower lip and buccal mucosa 2 months before his arrival at our hospital. Histopathological analysis confirmed a diagnosis of oral LP. He experienced a rapid dramatic improvement of both lesions within 4 weeks of the start of tacrolimus application. No significant irritation or recurrence was observed. Thus, topical tacrolimus is suggested as a well-tolerated, effective therapy for oral LP.
Comment in
-
The use of topical calcineurin inhibitors in the management of oral lichen planus.J Eur Acad Dermatol Venereol. 2007 Apr;21(4):554-6. doi: 10.1111/j.1468-3083.2006.01953.x. J Eur Acad Dermatol Venereol. 2007. PMID: 17373997 No abstract available.
Similar articles
-
Treatment of erosive oral lichen planus with topical tacrolimus.J Dermatolog Treat. 2004 Sep;15(5):308-14. doi: 10.1080/09546630410018247. J Dermatolog Treat. 2004. PMID: 15370399
-
Response of oral lichen planus to topical tacrolimus in 37 patients.Arch Dermatol. 2004 Dec;140(12):1508-12. doi: 10.1001/archderm.140.12.1508. Arch Dermatol. 2004. PMID: 15611431
-
Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus.Eur J Dermatol. 2003 Sep-Oct;13(5):466-70. Eur J Dermatol. 2003. PMID: 14693491
-
[Treatment of erosive oral lichen planus with topical tacrolimus].Zhonghua Kou Qiang Yi Xue Za Zhi. 2010 Mar;45(3):182-5. Zhonghua Kou Qiang Yi Xue Za Zhi. 2010. PMID: 20450689 Review. Chinese. No abstract available.
-
Topical tacrolimus and pimecrolimus in the treatment of oral lichen planus: an update.J Oral Pathol Med. 2010 Mar;39(3):201-5. doi: 10.1111/j.1600-0714.2009.00830.x. Epub 2009 Nov 20. J Oral Pathol Med. 2010. PMID: 19943858 Review.
Cited by
-
The onset risk of carcinoma in patients continuing tacrolimus topical treatment for oral lichen planus: a case report.Odontology. 2017 Apr;105(2):262-266. doi: 10.1007/s10266-016-0255-4. Epub 2016 Jul 1. Odontology. 2017. PMID: 27368962 Free PMC article.
-
New Functions of Classical Compounds against Orofacial Inflammatory Lesions.Medicines (Basel). 2018 Nov 1;5(4):118. doi: 10.3390/medicines5040118. Medicines (Basel). 2018. PMID: 30388792 Free PMC article. Review.
-
Oral lichen planus treated with tacrolimus 0.1%.Int J Clin Exp Med. 2013 Oct 25;6(10):917-21. eCollection 2013. Int J Clin Exp Med. 2013. PMID: 24260597 Free PMC article.
-
Analysis of the Efficacy of Two Treatment Protocols for Patients with Symptomatic Oral Lichen Planus: A Randomized Clinical Trial.Int J Environ Res Public Health. 2020 Dec 23;18(1):56. doi: 10.3390/ijerph18010056. Int J Environ Res Public Health. 2020. PMID: 33374791 Free PMC article. Clinical Trial.
-
Candida is a protractive factor of chronic oral ulcers among usual outpatients.Jpn Dent Sci Rev. 2018 May;54(2):52-58. doi: 10.1016/j.jdsr.2017.12.001. Epub 2018 Jan 12. Jpn Dent Sci Rev. 2018. PMID: 29755615 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources